Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
about
Micronutrient Antioxidants and Nonalcoholic Fatty Liver DiseaseDiagnostics and Treatment of Hepatocellular Carcinoma in 2016: Standards and DevelopmentsNon-Alcoholic Fatty Liver Disease and Extra-Hepatic CancersMicroRNAs in the Evaluation and Potential Treatment of Liver DiseasesVascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and FerritinNAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics ApproachFatty liver diseases, bile acids, and FXRPathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal CellsSchisandrin B: A Double-Edged Sword in Nonalcoholic Fatty Liver DiseaseImmune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic TargetsFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVMetabolism Disrupting Chemicals and Metabolic DisordersHepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management.Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic.Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease.Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease.Editorial: "Lean" NAFLD: Metabolic Obesity with Normal BMI… Is It in the Genes?Formulation for Effective Screening and Management of Nonalcoholic Steatohepatitis: Noninvasive NAFLD Management Strategy.Long-Term Adult Feline Liver Organoid Cultures for Disease Modeling of Hepatic SteatosisAssociation of Non-alcoholic Fatty Liver Disease with Conduction Defects on Electrocardiogram.Homocysteine Induces Hepatic Steatosis Involving ER Stress Response in High Methionine Diet-Fed MiceDoes bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage.Nonalcoholic Fatty Liver Disease (NAFLD) and Risk of Cardiac Arrhythmias: A New Aspect of the Liver-heart Axis.Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cellsPrevalence of Non Alcoholic Fatty Liver Disease and its Association with Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.Morinda citrifolia Linn. (Noni) and Its Potential in Obesity-Related Metabolic Dysfunction.Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALDEffect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study.To screen or not to screen? Celiac antibodies in liver diseases.Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.Characterisation of liver fat in the UK Biobank cohort.Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population.PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
P2860
Q26738646-DCD4BB17-108E-4655-8594-4EB939D4C3E6Q26740315-C51DF406-E635-40D0-AD17-C8B4ABA5204EQ26749045-A610EEE7-FB8A-46CC-BA0E-82C5E4DFA677Q26750448-47E765E7-74A1-4F61-B7F1-4978FCD47CB4Q26750865-008464FA-3236-4257-B9EC-0950B1F57F6FQ26750955-E81539AF-C1A6-4F8C-B66F-82A2ECA5166DQ26753043-78160E8D-35C3-43E6-BE58-A8C29879A5B4Q28068199-11F21097-E4C7-4B04-8ACF-971C5333298FQ28071596-7ECE66FB-A586-4A3C-9FC9-0DEF4CACD1E7Q28078342-2CE699AC-A053-4509-B7A0-FBC2504A86B4Q28079713-A5DBCDE5-C4A1-44DD-B133-5CDB3802CA4EQ28079826-B51703DF-C2FA-412E-B788-34EC2F53AE88Q29248099-0962DA46-5A44-455F-A1F5-5BC70BF7C624Q30234574-E77D44D3-3EC5-41DF-A059-EFCADC242E63Q30235846-716181A3-9B0E-420E-B521-1276CA03875DQ30238749-073A956C-DF45-4611-94A1-756EC4D586B9Q30238933-23F3AED8-F985-439B-AD28-560850BC9D25Q30241387-BBF2731B-D35D-4519-8687-5C5C5A73BD84Q30244335-BE5EAA43-B367-4039-8868-0F879A680C2FQ30251565-56707B1A-0D65-494E-A42D-0C1A8C2A9E3CQ30275106-CDF252E0-5E34-4B06-A146-7EFA832B8DBCQ30379871-51BCF58C-601B-4EC7-9E67-DC5E1A21FB1DQ33559685-C110E5DB-2E08-4F81-B299-C2044CA29EFFQ33591227-6FE28702-08C2-42C3-B881-D52F320BF92DQ33616674-ED717112-6057-4BD0-8434-497AB685E5B6Q33693385-E2E90AA2-9682-4F74-A3BF-B19DFF29EEBBQ33751826-6FD6D3C5-F731-4CB1-A093-390247C00A9FQ33805278-21CBC7DE-ACCC-48B8-9F97-96FECECA6E7EQ33807881-58ED131C-20C5-4B0E-A0CD-F11FB1A4F59DQ33832177-7D1E8220-BADD-4571-9F9C-5C2D4149A883Q33840930-644C555E-768B-4B03-84B6-0764D3C44B4BQ33844463-AE614C3F-80DB-4FC8-B150-D7D0DC3C6023Q33851783-E9CFB75B-B5AF-43B2-8278-2AF3E6643E6BQ33852213-566C4654-A144-46DD-8AB7-D7895200119CQ33858997-95260EC5-350F-442E-BC14-53635FAA040EQ34551744-1B36A2D7-C38A-4EF0-AFD9-F986C2041B48Q36267994-0D1D8F50-359A-4A9C-8F50-60BA024B46C2Q36291704-331D005D-C7A6-4248-A95E-4D4426A55542Q36306317-AFC8C987-D47E-4592-B5D5-A24D447BE7D6Q36939099-937A4B18-D040-4ADF-98AE-FE189150677B
P2860
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Global epidemiology of nonalco ...... ence, incidence, and outcomes.
@en
type
label
Global epidemiology of nonalco ...... ence, incidence, and outcomes.
@en
prefLabel
Global epidemiology of nonalco ...... ence, incidence, and outcomes.
@en
P2093
P356
P1433
P1476
Global epidemiology of nonalco ...... lence, incidence, and outcomes
@en
P2093
Dinan Abdelatif
Linda Henry
Mark Wymer
Yousef Fazel
Zobair M Younossi
P356
10.1002/HEP.28431
P407
P577
2016-02-22T00:00:00Z